Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2025 Earnings Call Transcript February 25, 2026
Arcus Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.89, expectations were $-1.11.
Operator: Hello, everyone, and thank you for joining the Arcus Biosciences Full Year and Fourth Quarter 2025 Earnings and Financial Results Call. My name is Claire and I’ll be coordinating your call today. [Operator Instructions] I will now hand over to Holli Kolkey from Arcus Biosciences to begin. Please...
